Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Pennsylvania
With
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ages 18 to 65 years old.
Diagnosis of type 2 diabetes.
Individuals with a BMI of 30-40 kg/m2
Approval for bariatric surgery (as confirmed by medical evaluation)
Insurance coverage for bariatric surgery
Willingness to change diet, physical activity and weight.
Ability to communicate with the investigator and be legally competent, provide written informed consent.
You may not be if
Diagnosis of type 1 diabetes, diagnosis of maturity-onset diabetes of the young (MODY), or latent autoimmune diabetes in adults (LADA) (all of which are associated with ß-cell destruction), daily insulin requirements \> 100 units, and poor preoperative glycemic control, as indicated by a HbA1c \> 6.5 - ≤ 8.5 or HbA1c \> 8.6 - \< 9.5 (individuals with this HbA1c value will require medical clearance and approval from the study physician).
Use of medications known to significantly increase body weight, such as chronic systemic steroids or certain psychiatric medications (e.g., lithium tricyclic antidepressants and anti-psychotic agents).
Non-ambulatory individuals, defined as those who are unable to walk at least one city block without a cane or walker.
Any major illnesses that the surgical team believes present too great a risk for surgery. These include severe cardiac and pulmonary diseases, as well as uncontrolled type 2 diabetes.
Evidence of major depression or other psychiatric disorder (schizophrenia, bipolar disorder, major depression, bulimia nervosa, etc.) that is uncontrolled, poorly controlled, or, in the opinion of the Investigators, significantly interferes with daily living and functioning.
Any current (past 12 months) substance abuse or dependence disorder.
Participants with moderate anemia (Hgb \< 12 mg/dl for men and Hgb \< 11 mg/dl for women)
Conditions that may falsely elevate or decrease HbA1c values, including hemolytic or iron-deficiency anemia, hemoglobinopathies, and uremia.
Abnormal laboratory tests which are clinically significant per the investigator.
Clareo Health | Surgery Or Lifestyle Intervention for Type 2 Diabetes (SOLID)
